Related Experiment Video
Updated: Apr 30, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Insights
Antihypertensive therapy may help prevent dementia and Alzheimer's disease. Studies suggest starting treatment in middle age or old age, with Angiotensin II Receptor Blockers (ARBs) potentially being most effective.
Area of Science:
- Neurology
- Cardiology
- Gerontology
Context:
- Hypertension is a known risk factor for cognitive decline.
- The efficacy of antihypertensive therapy in preventing dementia and Alzheimer's disease remains under investigation.
- Existing epidemiological data and meta-analyses suggest potential benefits.
Purpose:
- To review the current evidence on the role of antihypertensive therapy in dementia prevention.
- To explore the potential benefits of different antihypertensive drug classes, particularly ARBs.
- To assess the impact of treatment timing (middle-age vs. elderly) on dementia risk.
Summary:
- Epidemiological studies indicate that antihypertensive therapy initiated in middle age may reduce dementia risk.
- Meta-analyses, including the HYVET study, suggest blood pressure reduction in the elderly can also be protective against dementia.
- Network meta-analyses and large cohort studies point to Angiotensin II Receptor Blockers (ARBs) as potentially more effective than other antihypertensive agents in preventing dementia or Alzheimer's disease.
Impact:
- Antihypertensive treatment may be a valuable strategy for managing hypertensive individuals at risk of cognitive impairment.
- Further large-scale clinical trials are necessary to definitively establish the role of antihypertensive therapy in dementia prevention.
- Early intervention with antihypertensives, possibly ARBs, could offer a novel approach to mitigating dementia progression.
Abstract:
Hypertension is well known to one of the risk factors to reduce cognitive function, however, it is still unclear whether anti-hypertensive therapy is effective to prevent development of dementia or Alzheimer's disease. Epidemiological studies suggested antihypertensive therapy from the middle-age could reduce risk of dementia. The meta-analysis including HYVET also suggested blood pressure lowering from the elderly might be also effective to prevent development of dementia. The network meta-analysis and the cohort study using mega-data bank suggested ARB might be effective to prevent development of dementia or Alzheimer's disease compared to administration with other anti-hypertensive drugs. Although the further major clinical investigation is required, anti-hypertensive treatment might be useful to manage hypertensive patients with dementia.
Related Concept Videos
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies

